← Leaderboards
Stanley L Hazen
Cleveland Clinic Foundation
$59,550,078
Attributed
$71,126,551
Total exposure
37
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.9M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$123,179,184 · 41
By mechanism
P01$70,961,247 · 17
R01$37,843,423 · 13
P20$4,781,412 · 1
U54$3,866,361 · 1
P50$2,646,705 · 1
M01$1,677,020 · 1
Top collaborators
- Wai Hong Wilson Tang13 shared
- Dariush Mozaffarian6 shared
- Paul E Dicorleto3 shared
- D. Geoffrey Vince3 shared
Others in their field
Top investigators on “Link”
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- David R. Weir · University Of Michigan At Ann Arbor$206,261,870
- Clare E Reimers · Gordon Research Conferences$205,233,456
- Demian A Bailey · Oregon State University$205,233,456
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
Research focus
LinkCardiovascular DiseasesAtherosclerosisPathway InteractionsIn VivoProgramsPlasmaClinical ResearchBaseAnimal ModelCardiovascular Disorder RiskInflammationGenerationsEventOxidationCardiovascular SystemNovel DiagnosticsDiagnosticParticipantReportingComplexMediatingMetabolismPhenotype
Grant awards (166)
Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and Mortality$1,327,902
R01 · FY2025 · HL
Artificial sweeteners and cardiovascular disease$796,395
R01 · FY2025 · HL · contact PI
Gut microbial dietary phenylalanine metabolism and heart failure$790,067
R01 · FY2025 · HL · contact PI
Nutrition, terminal NAD metabolites and cardiovascular disease$784,329
R01 · FY2025 · HL · contact PI
Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and Mortality$1,378,637
R01 · FY2024 · HL
Gut microbial dietary phenylalanine metabolism and heart failure$790,067
R01 · FY2024 · HL · contact PI
Nutrition, terminal NAD metabolites and cardiovascular disease$784,329
R01 · FY2024 · HL · contact PI
Gut Microbiota and Cardiometabolic Diseases$2,425,292
P01 · FY2023 · HL · contact PI
Gut Flora metabolism of dietary carnitine and cardiovascular disease$786,871
R01 · FY2023 · HL · contact PI
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes$523,250
P01 · FY2023 · HL · contact PI
Core A: Administrative/Clinical/Bioinformatics Core$217,350
P01 · FY2023 · HL · contact PI
Gut Microbiota and Cardiometabolic Diseases$2,423,889
P01 · FY2022 · HL · contact PI
Gut Flora metabolism of dietary carnitine and cardiovascular disease$786,871
R01 · FY2022 · HL · contact PI
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes$523,250
P01 · FY2022 · HL · contact PI
Core A: Administrative/Clinical/Bioinformatics Core$217,350
P01 · FY2022 · HL · contact PI
Gut Microbiota and Cardiometabolic Diseases$2,423,889
P01 · FY2021 · HL · contact PI
Gut Flora metabolism of dietary carnitine and cardiovascular disease$786,871
R01 · FY2021 · HL · contact PI
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes$523,250
P01 · FY2021 · HL · contact PI
Gut Flora metabolism of dietary carnitine and cardiovascular disease$402,500
R01 · FY2021 · HL · contact PI
Core A: Administrative/Clinical/Bioinformatics Core$217,350
P01 · FY2021 · HL · contact PI
Gut Microbiota and Cardiometabolic Diseases$2,423,889
P01 · FY2020 · HL · contact PI
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD$1,147,817
R01 · FY2020 · HL
Gut Flora metabolism of dietary carnitine and cardiovascular disease$786,057
R01 · FY2020 · HL · contact PI
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes$523,250
P01 · FY2020 · HL · contact PI
Core A: Administrative/Clinical/Bioinformatics Core$217,350
P01 · FY2020 · HL · contact PI
Gut Microbiota and Cardiometabolic Diseases$2,445,300
P01 · FY2019 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,848,931
P01 · FY2019 · HL · contact PI
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD$1,145,137
R01 · FY2019 · HL
HDL Structure, Function and Dysfunction$779,230
R01 · FY2019 · HL · contact PI
Diet, Gut Microbiota, and Heart Failure$771,227
R01 · FY2019 · HL
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD$737,321
R01 · FY2019 · HL · contact PI
Project 1:Oxidant Stress and Cardiovascular Disease$396,249
P01 · FY2019 · HL · contact PI
Admin Core: Oxidation in Inflammation and Cardiovascular Disease$158,968
P01 · FY2019 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,848,931
P01 · FY2018 · HL · contact PI
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD$1,151,732
R01 · FY2018 · HL
HDL Structure, Function and Dysfunction$779,230
R01 · FY2018 · HL · contact PI
Diet, Gut Microbiota, and Heart Failure$771,227
R01 · FY2018 · HL
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD$737,321
R01 · FY2018 · HL · contact PI
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease$689,607
R01 · FY2018 · DK
Project 1:Oxidant Stress and Cardiovascular Disease$396,249
P01 · FY2018 · HL · contact PI
Admin Core: Oxidation in Inflammation and Cardiovascular Disease$158,968
P01 · FY2018 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,848,931
P01 · FY2017 · HL · contact PI
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD$1,207,201
R01 · FY2017 · HL
HDL Structure, Function and Dysfunction$779,230
R01 · FY2017 · HL · contact PI
Diet, Gut Microbiota, and Heart Failure$771,227
R01 · FY2017 · HL
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD$737,321
R01 · FY2017 · HL · contact PI
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease$689,607
R01 · FY2017 · DK · contact PI
Project 1:Oxidant Stress and Cardiovascular Disease$396,249
P01 · FY2017 · HL · contact PI
Admin Core: Oxidation in Inflammation and Cardiovascular Disease$158,968
P01 · FY2017 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,848,928
P01 · FY2016 · HL · contact PI
HDL Structure, Function and Dysfunction$793,855
R01 · FY2016 · HL · contact PI
Diet, Gut Microbiota, and Heart Failure$785,852
R01 · FY2016 · HL
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD$737,321
R01 · FY2016 · HL · contact PI
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease$689,607
R01 · FY2016 · DK · contact PI
Functional Cardio-Metabolomics$670,571
P20 · FY2016 · HL · contact PI
Project 1:Oxidant Stress and Cardiovascular Disease$396,249
P01 · FY2016 · HL · contact PI
Admin Core: Oxidation in Inflammation and Cardiovascular Disease$158,965
P01 · FY2016 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,863,557
P01 · FY2015 · HL · contact PI
Functional Cardio-Metabolomics$1,127,142
P20 · FY2015 · HL · contact PI
Gut Flora Metabolism of Dietary Phosphatidylcholine and CVD$737,321
R01 · FY2015 · HL · contact PI
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease$689,607
R01 · FY2015 · DK · contact PI
Carbamylation, smoking, and asthma$461,005
P01 · FY2015 · HL · contact PI
Project 1:Oxidant Stress and Cardiovascular Disease$396,249
P01 · FY2015 · HL · contact PI
Admin Core: Oxidation in Inflammation and Cardiovascular Disease$158,968
P01 · FY2015 · HL · contact PI
HDL Structure and its Function in Atherosclerosis$2,277,257
P01 · FY2014 · HL · contact PI
The Cleveland Clinic Innovation Accelerator$1,809,199
U54 · FY2014 · HL
Oxidation in Inflammation and Cardiovascular Disease$1,795,781
P01 · FY2014 · HL · contact PI
Functional Cardio-Metabolomics$1,134,238
P20 · FY2014 · HL · contact PI
The Cleveland Clinic Innovation Accelerator$951,000
U54 · FY2014 · HL
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease$709,072
R01 · FY2014 · HL · contact PI
HDL Structure and its Function in Atherosclerosis$587,594
P01 · FY2014 · HL · contact PI
HDL Structure/Function and Dysfunction$556,683
P01 · FY2014 · HL · contact PI
Carbamylation, smoking, and asthma$459,333
P01 · FY2014 · HL · contact PI
Myeloperoxidase, oxidant stress and Atherogenesis$256,547
P01 · FY2014 · HL · contact PI
Administration Core$256,539
P01 · FY2014 · HL · contact PI
Administrative Core$153,860
P01 · FY2014 · HL · contact PI
HDL Structure and its Function in Atherosclerosis$2,212,194
P01 · FY2013 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,744,472
P01 · FY2013 · HL · contact PI
Functional Cardio-Metabolomics$1,138,008
P20 · FY2013 · HL · contact PI
The Cleveland Clinic Innovation Accelerator$1,106,162
U54 · FY2013 · HL
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease$688,811
R01 · FY2013 · HL · contact PI
HDL Structure/Function and Dysfunction$540,778
P01 · FY2013 · HL · contact PI
Carbamylation, smoking, and asthma$443,649
P01 · FY2013 · HL · contact PI
Myeloperoxidase, oxidant stress and Atherogenesis$249,218
P01 · FY2013 · HL · contact PI
Administration Core$249,208
P01 · FY2013 · HL · contact PI
Administrative Core$149,464
P01 · FY2013 · HL · contact PI
HDL Structure and its Function in Atherosclerosis$2,323,733
P01 · FY2012 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,832,428
P01 · FY2012 · HL · contact PI
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease$723,542
R01 · FY2012 · HL · contact PI
Functional Cardio-Metabolomics$711,453
P20 · FY2012 · HL · contact PI
HDL Structure/Function and Dysfunction$568,042
P01 · FY2012 · HL · contact PI
Carbamylation, smoking, and asthma$466,018
P01 · FY2012 · HL · contact PI
Myeloperoxidase, oxidant stress and Atherogenesis$261,781
P01 · FY2012 · HL · contact PI
Administration Core$261,775
P01 · FY2012 · HL · contact PI
Administrative Core$157,000
P01 · FY2012 · HL · contact PI
HDL Structure and its Function in Atherosclerosis$2,323,733
P01 · FY2011 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,832,429
P01 · FY2011 · HL · contact PI
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease$727,400
R01 · FY2011 · HL · contact PI
HDL Structure/Function and Dysfunction$564,580
P01 · FY2011 · HL · contact PI
Carbamylation, smoking, and asthma$466,018
P01 · FY2011 · HL · contact PI
PHOSPHOLIPID OXIDATION AND THE SCAVENGER RECEPTOR$416,951
P01 · FY2011 · HL · contact PI
Myeloperoxidase, oxidant stress and Atherogenesis$261,779
P01 · FY2011 · HL · contact PI
Administration Core$261,775
P01 · FY2011 · HL · contact PI
Administrative Core$156,043
P01 · FY2011 · HL · contact PI
CD36, A SCAVENGER RECEPTOR AND HDL, HIGH DENSITY LIPOPROTEIN$21,926
P41 · FY2011 · RR · contact PI
HDL Structure and its Function in Atherosclerosis$2,352,233
P01 · FY2010 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,946,679
P01 · FY2010 · HL · contact PI
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease$734,749
R01 · FY2010 · HL · contact PI
Biomarkers for Complications in Type 1 Diabetes (DCCT/EDIC)$673,794
R01 · FY2010 · DK · contact PI
HDL Structure/Function and Dysfunction$571,504
P01 · FY2010 · HL · contact PI
PHOSPHOLIPID OXIDATION AND THE SCAVENGER RECEPTOR$417,033
P01 · FY2010 · HL · contact PI
Myeloperoxidase, oxidant stress and Atherogenesis$382,160
P01 · FY2010 · HL · contact PI
Administrative Core$157,957
P01 · FY2010 · HL · contact PI
Administration Core$118,811
P01 · FY2010 · HL · contact PI
Biomarkers for Complications in Type 1 Diabetes (DCCT/EDIC)$76,679
R01 · FY2010 · DK · contact PI
Biomarkers for Complications in Type 1 Diabetes (DCCT/EDIC)$697,154
R01 · FY2009 · DK · contact PI
Determinants of Coronary Atherosclerotic Plaque Progression/Regression$536,404
P50 · FY2009 · HL · contact PI
PHOSPHOLIPID OXIDATION AND THE SCAVENGER RECEPTOR$417,115
P01 · FY2009 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,802,254
P01 · FY2008 · HL · contact PI
Determinants of Coronary Atherosclerotic Plaque Progression/Regression$550,231
P50 · FY2008 · HL · contact PI
PHOSPHOLIPID OXIDATION AND THE SCAVENGER RECEPTOR$417,193
P01 · FY2008 · HL · contact PI
Myeloperoxidase, Oxidant Stress and Atherogenesis$286,285
P01 · FY2008 · HL · contact PI
Myeloperoxidase, Oxidant Stress And Atherogenesis$258,449
P01 · FY2008 · HL · contact PI
CORE--Mass Spectrometry$127,083
P01 · FY2008 · HL · contact PI
Oxygen Radicals 2008 Gordon Research Conference$15,000
R13 · FY2008 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,781,820
P01 · FY2007 · HL · contact PI
Determinants of Coronary Atherosclerotic Plaque Progression/Regression$535,186
P50 · FY2007 · HL · contact PI
Myeloperoxidase, Oxidant Stress and Atherogenesis$459,158
P01 · FY2007 · HL · contact PI
PHOSPHOLIPID OXIDATION AND THE SCAVENGER RECEPTOR$424,840
P01 · FY2007 · HL · contact PI
CORE--Mass Spectrometry$211,536
P01 · FY2007 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,781,583
P01 · FY2006 · HL · contact PI
Determinants of Coronary Atherosclerotic Plaque Progression/Regression$520,015
P50 · FY2006 · HL · contact PI
Myeloperoxidase, Oxidant Stress and Atherogenesis$399,218
P01 · FY2006 · HL · contact PI
Phospholipid Oxidation and the Scavenger Receptor CD36$373,511
R01 · FY2006 · HL · contact PI
CORE--Mass Spectrometry$183,273
P01 · FY2006 · HL · contact PI
Oxidation in Inflammation and Cardiovascular Disease$1,778,269
P01 · FY2005 · HL
Determinants of Coronary Atherosclerotic Plaque Progression/Regression$504,869
P50 · FY2005 · HL
Triple Quadrupole Mass Spectrometer With HPLC System$500,000
S10 · FY2005 · RR
Myeloperoxidase, Oxidant Stress and Atherogenesis$394,476
P01 · FY2005 · HL
Phospholipid Oxidation and the Scavenger Receptor CD36$382,500
R01 · FY2005 · HL
TRIPLE QUADRUPOLE MASS SPECTROMETER WITH HPLC SYSTEM: CARDIOIVASCULAR$375,000
S10 · FY2005 · RR
Peroxidases and Asthma$306,000
R01 · FY2005 · HL
CORE--Mass Spectrometry$177,934
P01 · FY2005 · HL
TRIPLE QUADRUPOLE MASS SPECTROMETER WITH HPLC SYSTEM: IMMUNOLOGY$75,000
S10 · FY2005 · RR
TRIPLE QUADRUPOLE MASS SPECTROMETER WITH HPLC SYSTEM: MULTIPLE SCLEROSIS$50,000
S10 · FY2005 · RR
Oxidation in Inflammation and Cardiovascular Disease$1,778,637
P01 · FY2004 · HL
Phospholipid Oxidation and the Scavenger Receptor CD36$1,677,020
M01 · FY2004 · RR
Phospholipid Oxidation and the Scavenger Receptor CD36$382,500
R01 · FY2004 · HL
Myeloperoxidase, Oxidant Stress and Atherogenesis$380,225
P01 · FY2004 · HL
Peroxidases and Asthma$306,000
R01 · FY2004 · HL
Determinants of Atherosclerotic Plaque Progression$275,317
R01 · FY2004 · HL
CORE--Mass Spectrometry$172,392
P01 · FY2004 · HL
Myeloperoxidase, Oxidant Stress and Atherogenesis$127,500
R01 · FY2004 · HL
Core A-Administration and Biostatistics$95,444
P01 · FY2004 · HL
Phospholipid Oxidation and the Scavenger Receptor CD36$382,500
R01 · FY2003 · HL
Myeloperoxidase, Oxidant Stress and Atherogenesis$372,500
R01 · FY2003 · HL
Peroxidases and Asthma$306,000
R01 · FY2003 · HL
Phospholipid Oxidation and the Scavenger Receptor CD36$370,000
R01 · FY2002 · HL
MYELOPEROXIDASE, OXIDANT STRESS AND ATHEROGENESIS$328,708
R01 · FY2002 · HL
Peroxidases and Asthma$296,000
R01 · FY2002 · HL
TRIPLE QUADRUPOLE SPECTROMETRY SYSTEM$366,090
S10 · FY2001 · RR
MYELOPEROXIDASE, OXIDANT STRESS AND ATHEROGENESIS$254,653
R01 · FY2001 · HL
EOSINOPHIL PEROXIDASE AND THE ORIGINS OF ASTHMA$253,750
R01 · FY2001 · HL
MYELOPEROXIDASE, OXIDANT STRESS AND ATHEROGENESIS$64,902
R01 · FY2001 · HL
EOSINOPHIL PEROXIDASE AND THE ORIGINS OF ASTHMA$253,750
R01 · FY2000 · HL
MYELOPEROXIDASE, OXIDANT STRESS AND ATHEROGENESIS$247,237
R01 · FY2000 · HL